Has Synakis Successfully Closed Its Oversubscribed Pre-Seed Round?
Synakis Corp., a biotechnology company based in Toronto, has successfully closed an oversubscribed CAD $2.6 million pre-seed financing round. The funds are intended to advance...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info